Clinical Trials Browser

Interventional × Axitinib × Dermatologic × Clear all

NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

Phase 2 Recruiting

Melanoma, Skin Neoplasms

NCT04458259 2025-08-28

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Phase 1 Terminated

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT05070221 2021-10-07

Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis

Phase 1 Unknown

Melanoma

NCT01321437 2021-01-20

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

Phase 2 Completed

11 enrolled 12 charts

Melanoma

NCT01174238 2018-06-08

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma

Phase 2 Completed

40 enrolled 10 charts

Melanoma

NCT01533948 2018-05-09

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Phase 2 Terminated

25 enrolled 11 charts

Uveal Melanoma, Melanoma

NCT00094107 2012-06-26

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Phase 2 Completed

32 enrolled 9 charts

Melanoma, Skin Neoplasms